| 1 |
32118594 | Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study. | 2020 Nov/Dec |
1 |
| 2 |
30282452 | Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial. | 2019 Apr |
1 |
| 3 |
29145602 | Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. | 2018 Feb 1 |
1 |
| 4 |
29977534 | Thymidylate synthase expression in primary colorectal cancer as a predictive marker for the response to 5-fluorouracil- and oxaliplatin-based preoperative chemotherapy for liver metastases. | 2018 Jul |
1 |
| 5 |
28461099 | Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules. | 2017 Jun 10 |
2 |
| 6 |
22110208 | Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. | 2011 Nov |
4 |
| 7 |
22202337 | [The Relationship between the efficacy of mFOLFOX6 treatment and the expression of TS, DPD, TP, and ERCC-1 in unresectable colorectal cancer]. | 2011 Nov |
1 |
| 8 |
20020129 | Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. | 2010 Aug |
2 |
| 9 |
21224630 | [The expression of thymidylate synthase (TS) and excision repair complementing-1 (ERCC-1) protein in patients with unresectable colorectal cancer treated with mFOLFOX6 therapy]. | 2010 Nov |
2 |
| 10 |
19194123 | Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. | 2009 Feb |
2 |
| 11 |
17684476 | Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin? | 2008 Oct |
1 |
| 12 |
19020759 | Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. | 2008 Dec |
1 |
| 13 |
17273745 | Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. | 2007 Mar |
1 |
| 14 |
15057142 | Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells. | 2004 Apr |
4 |
| 15 |
15213713 | A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. | 2004 Jul 19 |
1 |
| 16 |
11953866 | Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity. | 2002 Apr 8 |
1 |
| 17 |
11705873 | Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies. | 2001 Nov |
1 |
| 18 |
11731512 | ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. | 2001 Dec 1 |
1 |